Administration of lipegfilgrastim in primary prophylaxis of febrile neutropenia during dose-dense chemotherapy in a patient with breast cancer — case report

The use of dose-dense or "dense-dose" complementary chemotherapy in early breast cancer has allowed significantly improve the four-year disease-free survival (DFS) rate, especially in a group of patients who are young an…